Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rank in Stocks #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Share Price
$240.45
Market Cap
$579.46B
Change (1 day)
0.51%
Change (1 year)
46.88%
Country
US
Trade Johnson & Johnson (JNJ)

Category

Price of JNJ with the market cap of B
Johnson & Johnson Johnson & Johnson
JNJ
$240.45
Market Capitalization of Johnson & Johnson(JNJ)
Market Cap: $579.46B
As of March 2026 Johnson & Johnson has a market cap of $579.46B. This makes Johnson & Johnson the world's 18th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Johnson & Johnson from 1962 to 2026
JNJ compared with Top 5 Most Popular stocks
Price of JNJ Asset B Mkt. of B Results
Johnson & Johnson Johnson & Johnson
$1,689.52 $579.46B
$4.072T +602.65%
Johnson & Johnson Johnson & Johnson
$1,517.43 $579.46B
$3.657T +531.08%
Johnson & Johnson Johnson & Johnson
$1,374.20 $579.46B
$3.312T +471.51%
Johnson & Johnson Johnson & Johnson
$1,099.32 $579.46B
$2.649T +357.19%
Johnson & Johnson Johnson & Johnson
$887.96 $579.46B
$2.140T +269.29%